John Wort

1.1k total citations
20 papers, 193 citations indexed

About

John Wort is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, John Wort has authored 20 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in John Wort's work include Pulmonary Hypertension Research and Treatments (15 papers), Cardiovascular Issues in Pregnancy (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). John Wort is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Cardiovascular Issues in Pregnancy (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). John Wort collaborates with scholars based in United Kingdom, Ireland and United States. John Wort's co-authors include Timothy W. Evans, Timothy D. Warner, Jane A. Mitchell, Laura Price, Scott D. Barnett, Rodney Hughes, Peter J. Engel, Eva M. Carmona, Joanna Pepke‐Żaba and Vasileios Kouranos and has published in prestigious journals such as European Heart Journal, European Respiratory Journal and Thorax.

In The Last Decade

John Wort

19 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wort United Kingdom 5 169 68 65 28 23 20 193
R Ewert Germany 6 168 1.0× 86 1.3× 26 0.4× 12 0.4× 16 0.7× 14 184
Ayşegül Şentürk Türkiye 9 111 0.7× 47 0.7× 31 0.5× 27 1.0× 5 0.2× 50 234
Jacek Górka Poland 9 103 0.6× 90 1.3× 24 0.4× 19 0.7× 8 0.3× 25 193
Ségolène Turquier France 7 179 1.1× 92 1.4× 16 0.2× 16 0.6× 16 0.7× 17 194
Elizabeth Pielsticker United States 6 239 1.4× 165 2.4× 14 0.2× 26 0.9× 51 2.2× 11 288
Charlotte Berlier Switzerland 10 215 1.3× 131 1.9× 7 0.1× 20 0.7× 18 0.8× 21 251
Benjamin M. Cohen United States 3 49 0.3× 33 0.5× 12 0.2× 24 0.9× 16 0.7× 4 207
Valeria C. Amatto Germany 4 342 2.0× 12 0.2× 147 2.3× 25 0.9× 3 0.1× 5 357
Sharad Chandra India 8 67 0.4× 114 1.7× 11 0.2× 97 3.5× 5 0.2× 61 210
Jeremy P. Feldman United States 9 235 1.4× 165 2.4× 17 0.3× 17 0.6× 39 1.7× 26 272

Countries citing papers authored by John Wort

Since Specialization
Citations

This map shows the geographic impact of John Wort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wort more than expected).

Fields of papers citing papers by John Wort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wort. The network helps show where John Wort may publish in the future.

Co-authorship network of co-authors of John Wort

This figure shows the co-authorship network connecting the top 25 collaborators of John Wort. A scholar is included among the top collaborators of John Wort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wort. John Wort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rothman, Alexander, Sofía S. Villar, Martin Law, et al.. (2024). Positioning Imatinib for Pulmonary Arterial Hypertension (PIPAH) study. European Heart Journal. 45(Supplement_1). 2 indexed citations
2.
Bunclark, Katherine, Alessandro Ruggiero, John Cannon, et al.. (2023). Left ventricular diastolic dysfunction attenuates outcomes in CTEPH. PA5177–PA5177. 1 indexed citations
3.
Bunclark, Katherine, James Liley, Alessandro Ruggiero, et al.. (2023). An open-source tool for risk prediction in operable CTEPH. PA5191–PA5191. 1 indexed citations
4.
Mason, Thomas, Chinthaka B. Samaranayake, Colm McCabe, et al.. (2023). Use of pulmonary vasodilator therapy in anti-synthetase syndrome-associated pulmonary hypertension. PA3495–PA3495. 1 indexed citations
5.
Piccari, Lucilla, John Wort, Federica Meloni, et al.. (2022). The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease. A5632–A5632.
6.
Wort, John, et al.. (2020). Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series. European Heart Journal - Case Reports. 4(6). 1–7. 4 indexed citations
7.
Shlobin, Oksana A., Vasileios Kouranos, Scott D. Barnett, et al.. (2020). Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry. European Respiratory Journal. 55(5). 1901747–1901747. 66 indexed citations
8.
Harries, Carl, Robert Tulloh, Aleksander Kempny, et al.. (2018). 24 Exercise capacity improvement in adult congenital heart disease patients switching from bosentan to macitentan therapy. Poster presentations. A8.4–A9. 1 indexed citations
9.
Mohamed, Nura A., Paul D. Lickiss, Hira Saleem, et al.. (2016). Metal Organic Framework as a Potential Drug Carrier for Pulmonary Arterial Hypertension. 1 indexed citations
10.
Ramakrishnan, Latha, Sharon Mumby, John Wort, & Gregory J. Quinlan. (2015). CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension. PA4901–PA4901. 1 indexed citations
11.
Ramakrishnan, Latha, Sharon Mumby, John Wort, & Gregory J. Quinlan. (2014). S36 Ferroportin Is Expressed In Human Pulmonary Artery Smooth Muscle Cells: Implications For Pulmonary Arterial Hypertension. Thorax. 69(Suppl 2). A21–A21. 1 indexed citations
12.
Ling, Yi, Martin Johnson, David G. Kiely, et al.. (2011). Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. 38. 4909. 1 indexed citations
13.
Johnson, Martin, DG Kiely, Robin Condliffe, et al.. (2011). S71 Influence of age on clinical phenotypes of incident idiopathic pulmonary arterial hypertension. Results from the pulmonary hypertension registry of the UK and Ireland. Thorax. 66(Suppl 4). A34–A35. 1 indexed citations
14.
Kiely, DG, Robin Condliffe, Simon Gibbs, et al.. (2011). S72 Prediction of survival in pulmonary arterial hypertension using survival equations. Results from the pulmonary hypertension registry of the UK and Ireland. Thorax. 66(Suppl 4). A35–A36. 1 indexed citations
15.
Coghlan, Gerry, Paul A. Corris, Seán Gaine, et al.. (2008). Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. 74 indexed citations
16.
Griffin, Nyree, Darlene Allen, John Wort, M. Rubens, & Simon Padley. (2007). Eisenmenger syndrome and idiopathic pulmonary arterial hypertension: do parenchymal lung changes reflect aetiology?. Clinical Radiology. 62(6). 587–595. 10 indexed citations
17.
Sykes, A., Rekha Badiger, John Wort, & Susan J. Copley. (2007). Multiple thoracic osteophytes presenting as mediastinal mass. Thorax. 62(2). 192–192. 1 indexed citations
18.
Wort, John, et al.. (2000). The Prostacyclin-Mimetic Cicaprost Inhibits Endogenous Endothelin-1 Release From Human Pulmonary Artery Smooth Muscle Cells. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S410–S413. 23 indexed citations
19.
Wort, John, et al.. (2000). The Prostacyclin-Mimetic Cicaprost Inhibits Endogenous Endothelin-1 Release From Human Pulmonary Artery Smooth Muscle Cells. Journal of Cardiovascular Pharmacology. 36. S410–S413. 2 indexed citations
20.
Singh, Shailendra Narayan, John Wort, & TW Evans. (1999). Inhaled nitric oxide in ARDS: modulator of lung injury?. Intensive Care Medicine. 25(9). 1024–1026. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Ewert Breakdown of academic impact, for papers by Ayşegül Şentürk Breakdown of academic impact, for papers by Jacek Górka Breakdown of academic impact, for papers by Ségolène Turquier Breakdown of academic impact, for papers by Elizabeth Pielsticker Breakdown of academic impact, for papers by Charlotte Berlier Breakdown of academic impact, for papers by Benjamin M. Cohen Breakdown of academic impact, for papers by Valeria C. Amatto Breakdown of academic impact, for papers by Sharad Chandra Breakdown of academic impact, for papers by Jeremy P. Feldman
Rankless by CCL
2026